WELCOME TO GROUP OTONKOSKI’S PAGES

Otonkoski lab is interested in nuclear reprogramming and genome editing, and how these can be applied to understand mechanisms behind pancreatic beta-cell failure leading to diabetes. We also operate a Core Facility service, the Biomedicum Stem Cell Centre (BSCC).
Read more

Research highlights

@OtonkoskiL

This year, we were featured on the covers of 3 top Journals! 😍 -Modeling β-cell ER-stress induced diabetes: YIPF5… twitter.com/i/web/status/1…

#stemcells derived islet transplantation is a promising treatment for #diabetes. How do #SC-islets compare to prima… twitter.com/i/web/status/1…